Dr. Perry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1919 E. Thomas Road
Phoenix, AZ 85016- Is this information wrong?
Summary
- Dr. Katherine Perry is a pediatric nephrologist in Phoenix, AZ and is affiliated with Phoenix Children's Hospital. She received her medical degree from University of Southern California School of Medicine and has been in practice 22 years. She is experienced in chronic kidney disease, renal osteodystrophy, and secondary hyperparathyroidism.
Education & Training
- University of California at Los AngelesMSc, Clinical Research, 2011
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Nephrology, 2003 - 2005
- Children's Hospital Los AngelesResidency, Pediatrics, 1999 - 2002
- Keck School of Medicine of the University of Southern CaliforniaClass of 1999
- Princeton UniversityBA, Chemistry, 1995
Certifications & Licensure
- AZ State Medical License 2022 - 2025
- CA State Medical License 2001 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Carmel Scholar Award 2007
- Della M. Mudd Award Childrens Hospital Los Angeles, 2002
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsGut microbiome, parathyroid hormone, and bone.Elizabeth Kermgard, Nadine Khouzam Chawla, Katherine Wesseling-Perry> ;Current Opinion in Nephrology and Hypertension. 2021 Jul 1
- Bone marrow adiposity inversely correlates with bone turnover in pediatric renal osteodystrophy.Ornatcha Sirimongkolchaiyakul, Renata C. Pereira, Barbara Gales, Justine Bacchetta, Isidro B. Salusky, Katherine Wesseling-Perry> ;Bone Reports. 2021 Jul 8
- 3 citationsAssociations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipientsBlair Limm-Chan, Katherine Wesseling-Perry, Meghan H. Pearl, Grace Jung, Eileen Tsai-Chambers, Patricia L. Weng, Mark R. Hanudel> ;Pediatric Nephrology. 2021 Apr 26
- Join now to see all
Journal Articles
- FGF23 inhibits extra-renal synthesis of 1,25-diydroxyvitamin D in human monocytesBacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M, J Bone Miner Res, 1/1/2013
- Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomographyBacchetta J, Wesseling-Perry K, Gilsanz V, Gales B, Pereira RC, Salusky IB, Pediatr Rheumatol Online J, 1/1/2013
- The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trialBacchetta J, Wesseling-Perry K , Kuizon B, Pereira RC, Gales B, Wang H, Elashoff R, Salusky IB, Clinical Journal of the American Society of Nephrology, 1/1/2013
- Join now to see all
Press Mentions
- Phoenix Children's Names Katherine Perry, MD, MS, Division Chief of NephrologyOctober 27th, 2022
Hospital Affiliations
- Phoenix Children'sPhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: